A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy
Completed
Boehringer Ingelheim
2010-12-21
This is a prospective, observational, open-label, multi-center study, which will provide
detailed information about the safety and efficacy of Twynsta tablets in Korean hypertensive
patients requiring combination therapy. This will present a convenient treatment option for
hypertension in Korean patients.
Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension
Completed
Boehringer Ingelheim
2011-03-01
This observational study is designed to evaluate the effects of Twynsta tablets with life
style modifications on blood pressure, quality of life, and other risk factors in Korean
patients with hypertension in a routine clinical practice setting.
The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine
Completed
Jeil Pharmaceutical Co., Ltd.
Phase 1
2015-02-01
A randomized, open-label, multiple-dose, crossover study to investigate the pharmacokinetic
drug interaction between rosuvastatin and telmisartan/amlodipine in healthy male volunteers
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
